FEATURES - INVESTOR RELATIONS - Merck takes its medicine - The family-controlled German drug giant has its first nonfamily chairman. And for public shareholders, Bernhard Scheuble may be the right potion.
Year of publication: |
2001
|
---|---|
Authors: | Lanchner, David |
Published in: |
Institutional investor / International edition. - New York, NY : Institutional Investor Inc., ISSN 0192-5660, ZDB-ID 3955412. - Vol. 26.2001, 3, p. 27-35
|
Saved in:
Saved in favorites
Similar items by person
-
Lanchner, David, (2003)
-
Lanchner, David, (2006)
-
Lanchner, David, (2006)
- More ...